Vascular failure: A hypothesis

Current Atherosclerosis Reports

Volumn 5, Issue 3, 2003, Pages 201-207

  Schwartz, Stephen M ^a   Geary, Randolph L ^a   Adams, Lawrence D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY DISEASE; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; HYPERTENSION; HYPOTHESIS; MATHEMATICAL MODEL; NONHUMAN; REVIEW; SMOOTH MUSCLE CONTRACTILITY; VASCULAR DISEASE; GENETICS; HUMAN; PATHOPHYSIOLOGY;

HUMANS; VASCULAR DISEASES;

EID: 0043199368     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-003-0025-y     Document Type: Review

References (51)

1. Wolinsky H, Glagov S: A lamellar unit of aortic medial structure and function in mammals. Circ Res 1967, 20:99-101.
2. Glagov S, Weisenberg E, Zarins CK, et al.: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987, 316:1371-1375.
3. Folkow B: Physiological aspects of primary hypertension. Physiol Rev 1982, 62:347-504.
4. Cho A, Mitchell L, Koopmans D, Langille BL: Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ Res 1997, 81:328-337.
5. Mulvany MJ, Hansen PK, Aalkjaer C: Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978, 43:854-863.
6. Mulvany MJ: Resistance vessel growth and remodeling: cause or consequence in cardiovascular disease. J Hum Hypertens 1995, 9:479-485.
7. Bray P, Agrotis A, Bobik A: Transforming growth factor-beta and receptor tyrosine kinase-activating growth factors negatively regulate collagen genes in smooth muscle of hypertensive rats. Hypertension 1998, 31:986-994.
8. Bezie Y, Lamaziere JM, Laurent S, et al.: Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1998, 18:1027-1034.
9. Himeno H, Crawford DC, Hosoi M, et al.: Angiotensin II alters aortic fibronectin independently of hypertension. Hypertension 1994, 23:823-826.
10. Deindl E, Buschmann I, Hoefer IE, et al.: Role of ischemia and of hypoxia-inducible genes in arteriogerlesis after femoral artery occlusion in the rabbit. Circ Res 2001, 89:779-786.
11. Hoefer IE, van Royen N, Buschmann IR, et al.: Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res 2001, 49:609-617.
12. Swynghedauw B, Baillard C: Biology of hypertensive cardiopathy. Curr Opin Cardiol 2000, 15:247-253.
13. Nicol RL, Frey N, Olson EN: From the sarcomere to the nucleus: role of genetics and signaling in structural heart disease. Annu Rev Genom Hum Genet 2000, 1:179-223.
14. Schaub MC, Hefti MA, Harder BA, Eppenberger HM: Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med 1997, 75:901-920.
15. Hunter JJ, Chien KR: Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999, 341:1276-1283.
16. Guyton AC: Kidneys and fluids in pressure regulation. Small volume but large pressure changes. Hypertension 1992, 19:12-18.
17. Dilley RJ, Schwartz SM: Vascular remodeling in the growth hormone transgenic mouse. Circ Res 1989, 65:1233-1240.
18. Bohlooly Y, Carlson L, Olsson B, et al.: Vascular function and blood pressure in GH transgenic mice. Endocrinology 2001, 142:3317-3323.
19. Guyton AC, Coleman TG, Cowley AW Jr, et al.: Systems analysis of arterial pressure regulation and hypertension. Ann Biomed Eng 1972, 1:254-281.
20. Karet FE, Lifton RP: Mutations contributing to human blood pressure variation. Recent Prog Horm Res 1997, 52:263-276.
21. O'Brien ER, Alpers CE, Stewart DK, et al.: Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res 1993, 73:223-231.
22. Mintz GS, Kovach JA, Javier SP, et al.: Geometric remodeling is the predominant mechanism of late lumen loss after coronary angioplasty [abstract]. Circulation 1993, 88(4 Pt 2):1-654.
23. Nissen SE: Clinical images from intravascular ultrasound: coronary disease, plaque rupture, and intervention - the inside view. Am J Cardiol 2001, 88:16K-18K.
24. Stadius ML, Gown AM, Kernoff R, Schwartz SM: Does sequential balloon injury of an artery lead to a different outcome than a single injury? An experimental study of angioplasty. Coronary Artery Dis 1996, 7:247-255.
25. Kandabashi T, Shimokawa H, Miyata K, et al.: Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation 2000, 101:1319-1323.
26. Hillebrands JL, Klatter FA, van Dijk WD, Rozing J: Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 2002, 8:194-195.
27. Shimokawa H: Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J 2000, 64:1-12.
28. Adams LD, Geary RL, McManus B, Schwartz SM: A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ Res 2000, 87:623-631.
29. D'Angelo DD, Sakata Y, Lorenz JN, et al.: Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A 1997, 94:8121-8126.
30. Adams JW, Sakata Y, Davis MG, et al.: Enhanced Gαq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci U S A 1998, 95:10140-10145.
31. Mende U, Kagen A, Cohen A, et al.: Transient cardiac expression of constitutively active Gαq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci U S A 1998, 95:13893-13898.
32. Akhter SA, Luttrell LM, Rockman HA, et al.: Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 1998, 280:574-577.
33. Offermanns S, Zhao LP, Gohla A, et al.: Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice. Eur Mol Biol Org J 1998, 17:4304-4312.
34. Sakata Y, Hoit BD, Liggett SB, et al.: Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice. Circulation 1998, 97:1488-1495.
35. Rogers JH, Tamirisa P, Kovacs A, et al.: RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J Clin Invest 1999, 104:567-576.
36. Rogers JH, Tsirka A, Kovacs A, et al.: RGS4 reduces contractile dysfunction and hypertrophic gene induction in Gαq overexpressing mice. J Mol Cell Cardiol 2001, 33:209-218.
37. Vuong TM, Chabre M: Deactivation kinetics of the transduction cascade of vision. Proc Natl Acad Sci U S A 1991, 88:9813-9817.
38. Kazlauskas A, Bowen-Pope DF, Seifert RA, et al.: Different effects of homo- and heterodimers of platelet-derived growth factor A and B chains on human and mouse fibroblasts. Eur Mol Biol Org J 1988, 7:3727-3735.
39. Somlyo AP, Somlyo AV: Signal transduction by C-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol (London) 2000, 522(Pt 2):177-185.
40. Kamm KE, Stull JT: Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 2001, 276:4527-4530.
41. Pfitzer G: Invited review: regulation of myosin phosphorylation in smooth muscle. J Appl Physiol 2001, 91:497-503.
42. Yamakawa T, Tanaka S, Numaguchi K, et al.: Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension 2000, 35:313-318.
43. Numaguchi K, Eguchi S, Yamakawa T, el al.: Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments. Circ Res 1999, 85:5-11.
44. Miao H, Li S, Hu YL, et al.: Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling. J Cell Sci 2002, 115:2199-2206.
45. Tzima E, del Pozo MA, Shattil SJ, et al.: Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignment. Eur Mol Biol Org J 2001, 20:4639-4647.
46. Lu J, Landerholm TE, Wei JS, et al.: Coronary smooth muscle differentiation from proepicardial cells requires RhoA-mediated actin reorganization and p160 Rho-kinase activity. Dev Biol 2001, 240:404-418.
47. Seasholtz TM, Zhang T, Morissette MR, et al.: Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip1) expression in the vasculature of hypertensive rats. Circ Res 2001, 89:488-495.
48. Lu Q, Sun EE, Klein RS, Flanagan JG: Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell 2001, 105:69-79.
49. Dulin NO, Sorokin A, Reed E, et al.: RGS3 inhibits G protein-mediated signaling via translocation to the membrane and binding to Gα 11. Mol Cell Biol 1999, 19:714-723.
50. Saitoh O, Masuho I, Terakawa I, et al.: Regulator of G protein signaling 8 (RGS8) requires its NH2 terminus for subcellular localization and acute desensitization of G protein-gated K+ channels. J Biol Chem 2001, 276:5052-5058.
51. Richardson RM, Marjoram RJ, Barr AJ, Snyderman R: RGS4 inhibits platelet-activating factor receptor phosphorylation and cellular responses. Biochem 2001, 40:3583-3588.